Dr. Pober received his BA from Haverford College in 1971 and his MD and PhD degrees from Yale University in 1977, performing his thesis research in the laboratory of Lubert Stryer. He trained in anatomic pathology both at Yale-New Haven Hospital and at Brigham and Women’s Hospital and performed post-doctoral research on HLA antigen structure in the laboratory of Jack Strominger in the Department of Biochemistry at Harvard University. He served on the faculty of Harvard Medical School in the Department of Pathology and as an attending Pathologist at Brigham and Women’s Hospital from 1981-1991. He moved to Yale School of Medicine in 1991 as Professor of Pathology and of Immunobiology, establishing an interdepartmental program in basic cardiovascular research program (Molecular Cardiobiology) that evolved into a translational research program (Vascular Biology and Transplantation or VBT) in 2000. In 2007, he stepped down from his role as director of VBT and started a new interdepartmental research program called Human and Translational Immunology. He currently serves as Yale’s inaugural Bayer Professor of Translational Medicine, as Professor and Vice Chair of the Department of Immunobiology for the Section of Human and Translational Immunology and as Professor of Pathology and Dermatology at the Yale School of Medicine. He is also a Visiting Fellow in the Department of Medicine at the University of Cambridge. Dr. Pober’s research interests center on the interactions between the human immune and vascular systems, both in host defense and in immune-mediated disorders with a specific focus on applications to organ replacement therapies. He has been a Searle Scholar, an Established Investigator of the American Heart Association, a recipient of a MERIT award from the National Heart, Lung and Blood Institute of the NIH, a recipient of the Warner-Lambert Parke-Davis (in 1988) and the Rous-Whipple (in 2011) awards from the American Society of Investigative Pathology and was the Russell Ross Memorial Lecturer in Vascular Biology of the ATVB council of the American Heart Association in 2010.